The Edith Busch Foundation (EBF) was founded in 2013 to support the research on scleroderma aiming at unraveling its pathogenesis and improving therapy.

The World Scleroderma Foundation (WSF) was founded in 2013 to promote global research into all aspects of scleroderma and is committed to improving the quality of life for scleroderma sufferers and their families.

The EBF & WSF are pleased to work together to promote innovative and high-quality research either by new or established investigators in fields related to scleroderma. The EBF & WSF are therefore inviting applications focusing on innovative research projects on scleroderma with translational perspectives.


Step 1
Applicants are invited to submit:

  1. Two page Letter of Interest (LOI) concerning the project structured as follows:
    • State of the art
    • Aims & objectives
    • Methods
    • Expected results
    • Budget
  2. The CV of the PI

Deadline for the application:.
Deadline: midnight, December 1st , 2022

The application must be sent by mail to the WSF office at the following mail address

Applications will be reviewed by an international selection committee in a 2-step procedure.

The LOIs that will be admitted to the second step will submit by mail to the WSF office the whole project  for evaluation before midnight, February  the 1st, 2022